Info Edge (India) Limited has appointed Himanshu Agarwal as its Whole-time Director and Chief Financial Officer, effective September 17, 2026, for a five-year term ending September 16, 2031. The appointment, subject to shareholder approval, aims to strengthen the company's finance leadership and corporate governance. Agarwal brings over three decades of experience in finance leadership, mergers and acquisitions, and business transformation across listed organisations in India and internationally.

The Board of Directors approved the appointment based on the recommendations of the Nomination & Remuneration Committee and Audit Committee. Agarwal, a qualified Chartered Accountant, Company Secretary, and Cost and Management Accountant, currently serves as Whole Time Director and Chief Financial Officer of Cohance Lifesciences Limited. He has held senior finance roles at ICI India Limited, AstraZeneca Pharma India Limited, AkzoNobel India Limited, Huhtamaki Oyj, and Bennett, Coleman and Co. Limited. He has been recognised with the Best CFO Award by the Institute of Chartered Accountants of India and among the Top 100 India CFOs by the CFO Institute.

The company stated that Agarwal is not related to any of the Directors and is not debarred from holding the office of Director by any SEBI order or other authority. Info Edge will intimate the stock exchanges upon Agarwal assuming office. The appointment follows Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Concurrently, the Board reconstituted its Audit and Nomination & Remuneration Committees effective June 27, 2026, to ensure continuity following the completion of Independent Director Ashish Gupta's term on July 20, 2026. Ms. Radha Rajappa was inducted as a Member of the Audit Committee, while Mr. Rajesh Magow joined the Nomination & Remuneration Committee as a Member and will assume the role of Chairman from July 21, 2026.

Audit Committee Composition

Nomination & Remuneration Committee Composition

Info Edge (India) Ltd has approved an investment of approximately ₹40 crore in its wholly-owned subsidiary, Startup Investments (Holding) Limited (SIHL). The capital infusion, approved by the Committee of Executive Directors on June 24, 2026, aims to strengthen SIHL's capacity to explore investment opportunities in technology companies and contribute to Alternative Investment Funds (AIFs). The transaction is expected to be completed within 30 days from the approval date.

Investment Details

The investment will be made through the acquisition of Compulsorily Convertible Debentures (CCDs). The transaction is classified as a related party transaction under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as SIHL is a wholly-owned subsidiary. It has been conducted on an arm's length basis, with no interest from the promoter or promoter group companies.

Subsidiary Financials and Background

Startup Investments (Holding) Limited, incorporated on March 4, 2015, operates primarily in India with a focus on direct or indirect investments in technology firms. As of March 31, 2025, the subsidiary reported a net worth of ₹203.31 crore and a loss after tax of ₹0.2 crore. The entity has recorded nil turnover over the last three financial years, including the periods 2023-24, 2024-25, and 2025-26.